Albany Molecular Research (AMRI)
Albany Molecular Research Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -3.807M | -24.41M | -5.852M | -0.568M | -1.467M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 4.535M | 20.52M | 4.617M | 4.43M | 4.397M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 5.706M | 0.578M | 2.16M | 2.366M | 2.298M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 10.24M | 21.10M | 6.777M | 6.796M | 6.695M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | 0.041M | 4.194M | -1.835M | -0.286M | -2.073M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Changes in Assets/Liabilities | -12.11M | 10.97M | -6.304M | 0.231M | -15.45M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -5.68M | 7.66M | -5.379M | 6.459M | -10.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -2.105M | -3.368M | -2.052M | -3.056M | -2.784M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 0.213M | 2.133M | 2.669M | 8.529M | 1.896M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -2.023M | -0.924M | 0.50M | 5.306M | -0.915M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -0.401M | -3.401M | -0.401M | -3.588M | 0.02M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | 0.233M | 0.00 | 0.288M | 0.089M | 0.294M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | -4.505M | -0.123M | 0.00 | 5.595M | -5.742M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -4.673M | -3.524M | -0.113M | 2.096M | -5.428M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.636M | -0.726M | -1.016M | 0.133M | 0.329M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -11.74M | 2.486M | -6.008M | 13.99M | -16.24M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 19.98M | 25.75M | 19.98M | 17.50M | 23.51M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 8.244M | 19.98M | 17.50M | 23.51M | 9.512M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
